Stryker (SYK) Equity Average (2009 - 2026)
Stryker (SYK) reported Equity Average of $22.7 billion for Q1 2026, up 120.36% year-over-year from $10.3 billion in Q1 2025, and up 2.7% quarter-over-quarter from $22.1 billion in Q4 2025.
Stryker (SYK) Equity Average (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of Equity Average data on file, last reported at $22.7 billion in Q1 2026.
- Equity Average for Q1 2026 came in at $22.7 billion, up 120.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.7 billion (up 120.36% YoY), and the FY2025 annual result was $11.0 billion, up 20.95% from the prior year.
- Equity Average grew to $22.7 billion in Q1 2026 per SYK's latest filing, from $22.1 billion in the prior quarter.
- Over five years, Equity Average peaked at $22.7 billion in Q1 2026 and troughed at $7.0 million in Q2 2024.
- A 5-year average of $11.0 billion and a median of $9.9 billion in 2024 frame the typical range for Equity Average.
- The sharpest annual moves came in 2024 and 2025: Equity Average tumbled 99.92% in 2024, then jumped 288135.71% in 2025.
- A 5-year view of Equity Average shows it stood at $8.3 billion in 2022, then jumped by 121.19% to $18.2 billion in 2023, then slumped by 45.69% to $9.9 billion in 2024, then soared by 123.02% to $22.1 billion in 2025, then advanced by 2.7% to $22.7 billion in 2026.
- Business Quant data shows SYK's Equity Average at $22.7 billion in Q1 2026, $22.1 billion in Q4 2025, and $20.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 52.42 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 22.70 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 49.03 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 13.05 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.85 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.53 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 7.18 Bn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 12.69 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.70 Bn |
| Dec 31, 2025 | 22.10 Bn |
| Sep 30, 2025 | 20.60 Bn |
| Jun 30, 2025 | 20.18 Bn |
| Mar 31, 2025 | 10.30 Bn |
| Dec 31, 2024 | 9.91 Bn |
| Sep 30, 2024 | 10.06 Bn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | 9.32 Bn |
| Dec 31, 2023 | 18.25 Bn |
| Sep 30, 2023 | 10.02 Bn |
| Jun 30, 2023 | 8.60 Bn |
| Mar 31, 2023 | 7.56 Bn |
| Dec 31, 2022 | 8.25 Bn |
| Sep 30, 2022 | 8.25 Bn |
| Jun 30, 2022 | 992.50 Mn |
| Mar 31, 2022 | 708.00 Mn |
| Dec 31, 2021 | 6.82 Bn |
| Sep 30, 2021 | 6.62 Bn |
| Jun 30, 2021 | 431.50 Mn |